Katherine O Hara and Vance Wheelock | GenomeWeb

Katherine O’Hara will become senior vice president and general counsel of PerkinElmer on May 2, the company said this week. Most recently, she was vice president and associate general counsel for Avon Products. Prior to that, she was an associate at Davis Polk & Wardwell in New York, where she focused on capital markets transactions for global clients. Before that, O’Hara was a leader of the Argentine business unit of Morgan Guaranty Trust Company of New York.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.